Managed Account Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Managed Account Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$9K	Buy	+1,138	New	+$5.52K	﹤0.01%	2904

Other funds holding SGYP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Managed Account Advisors's SGYP Position: Q2 2015 in Review

Managed Account Advisors opened a new position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2015: 1,138 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #2904 among its holdings.

123 funds tracked by Wall St. Rank hold SGYP as of Q2 2015.

Managed Account Advisors held 1,138 shares of Synergy Pharmaceuticals, Inc Common Stock worth $9K as of Q2 2015.
Synergy Pharmaceuticals, Inc Common Stock was a new Managed Account Advisors position in Q2 2015.
Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2904 holding.
123 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.